158 related articles for article (PubMed ID: 1981750)
1. Effects of dopamine D1 and dopamine D2 receptor agonists on coronary and peripheral hemodynamics.
Zhao RR; Fennell WH; Abel FL
Eur J Pharmacol; 1990 Nov; 190(1-2):193-202. PubMed ID: 1981750
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
3. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
Kopia GA; Valocik RE
J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
6. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
McCoy CE; Douglas FL; Goldberg LI
Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
[TBL] [Abstract][Full Text] [Related]
7. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR
Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of dopamine1- and dopamine2-receptor agonists on the cAMP generating system in canine coronary and renal arteries.
Wang WZ; Zhao RR; Qin FZ
Methods Find Exp Clin Pharmacol; 1994 Dec; 16(10):691-6. PubMed ID: 7723468
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
Van der Niepen P; Schoors DF; Dupont AG
Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
Shebuski RJ; Smith JM; Ruffolo RR
Pharmacology; 1988; 36(1):35-43. PubMed ID: 2893393
[TBL] [Abstract][Full Text] [Related]
11. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
Clark KL; Robertson MJ; Drew GM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
[TBL] [Abstract][Full Text] [Related]
12. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
Lokhandwala MF; Watkins HO; Dlewati A
Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Evans AM; Green KL
Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
[TBL] [Abstract][Full Text] [Related]
14. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
Nishiyama S; Yoshikawa M; Yamaguchi I
J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
[TBL] [Abstract][Full Text] [Related]
15. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cardiorenal and emetic effects of dopamine prodrugs docarpamine (TA-870) and levodopa in dogs.
Nishiyama S; Kanno K; Yamaguchi I
J Pharmacobiodyn; 1991 Mar; 14(3):120-5. PubMed ID: 1679131
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Goldberg LI
Am J Med; 1984 Oct; 77(4A):37-44. PubMed ID: 6148892
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
